Colombian Experience on the Treatment of mild Persistent Asthma with Ciclesonide
Experiencia Colombiana en el Tratamiento del Asma Leve Persistente con Ciclesonida
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Show authors biography
Objective: The aim of this observational study was to collect information about the effectiveness and safety of Ciclesonide on treatment of mildpersistent asthma in a cohort population in Colombia.
Material and methods: Longitudinal and descriptive study of a cohort without group control. Inclusion data from 2005 to 2006. We showed data of 264 clinical records of patients with persistent asthma diagnosis.
Results: A homogenous distribution by sort is observed (52% of men and 48% women). The average age was 31.7 years (standard deviation of 19.5 years). Before the beginning of ciclesonide, 5.7% of patients had not used medicines to treat the asthma, only 2.6% had used inhaled or oral corticosteroids, 23.5% had used one drug and 42.4% used 3 or more drugs. The lack of effectiveness of previous treatment was the main reason to initiate ciclesonide. At the last evaluation 93% of the patients described as “good to excellent” the performance of ciclesonide.
Conclusions: Ciclesonide is an effective and safe corticosteroid, useful for the treatment of patients greater to 6 years of age with mild persistent asthma. There are necessary programs of medical education that help to improve the level of knowledge on the treatment of asthma, because is observed lack of knowledge on therapeutic resources as it is the case of the inhaled corticotherapy
Article visits 26 | PDF visits 32
Downloads
- Louis C, Mitchell AA. Post-marketing surveillance using pharmacy based cohorts: results of a pilot study. Pharmacoepidemiology and Drug Safety 2005;14:289-295.
- Dennis R, Caraballo L, García E, Caballero A, Aristizabal G, Córdoba H, et al. Asthma and other allergic conditions in Colombia: a study in 6 cities. Ann Allergy Asthma Immunol 2004;93:568-574.
- Neffen H, Fristcher C, Cuevas SF, Levy G, Chiarella P, Soriano JB, et al. Asthma control in Latin America: the asthma insights and reality in Latin America survey. Pan Am J Public Health 2005;17(3):191-197.
- Global Innitiative for Asthma (GINA). Global strategy for asthma management and prevention. NHLBI/WHO Report. Bethesda, MD: Nacional Institutes of Health, Nacional Herat, Lung and Blood Institute; 2002 (NIH Publication No. 02-3659).
- Revicki DA, Frank L. Pharmaeoeconomics evaluation in the real world. Pharmacoeconomics 1999;15(5):423-434
- Chapman KR, Patel P, D ́Urzo AD, Mehra S, Oedekoven C, Engelstätter, et al. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma. Allergy 2004;1-8
- Reynolds NA, Scout LJ. Ciclesonide. Drugs 2004;64(5):511-519
Information
Journal history
Keywords
QR code
Funding
Directories and indexes
